Rimonabant clinical trials
Also written SR141716.
How each study uses Rimonabant is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Rimonabant studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- 19 Jun 2006 · Acomplia · EMEA/H/C/000666 (EMA; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
46 studies that test it; most in 2007 (9)
| Year | Studies |
|---|---|
| 2001 | 4 |
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 5 |
| 2005 | 6 |
| 2006 | 7 |
| 2007 | 9 |
| 2008 | 6 |
| 2021 | 1 |
| 2022 | 1 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 38 · Other 8
Sanofi (35) · Sinfatin S.L (3) · Hospital Nacional de Parapléjicos de Toledo (2) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1) · The Scripps Research Institute (1) · Aristotle University Of Thessaloniki (1) · Weill Medical College of Cornell University (1) · University of Maryland, Baltimore (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Rimonabant.
- Aug 2027Effect of Rimonabant on Hand Function in Patients With Spinal Cord InjuryPhase 1/2 · Sinfatin S.L
Studies
Open first, then newest update. How each study uses Rimonabant is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 46
- Rimonabant for Cognitive Impairment in People With Post-COVID-19 SyndromeNot yet recruitingPhase 2Sinfatin S.LNCT07930637Written as Rimonabant
- Rimonabant for Improving Walking Ability in Patients With Chronic StrokeNot yet recruitingPhase 2Sinfatin S.LNCT07913763Written as Rimonabant
- Effect of Rimonabant on Hand Function in Patients With Spinal Cord InjuryActive, not recruitingPhase 1/2Sinfatin S.LNCT07843108Written as Rimonabant
- Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi SyndromeTerminatedPhase 3Weill Medical College of Cornell UniversityNCT00603109Written as rimonabant
- Effects of CB1 Antagonist/Reverse Agonist Rimonabant on Walking Abilities in Incomplete Spinal Cord InjuryStatus unknownPhase 2Hospital Nacional de Parapléjicos de ToledoNCT05622994Written as Rimonabant
- Effects of Rimonabant on Walking Abilities in Incomplete Spinal Cord InjuryCompletedPhase 1/2Hospital Nacional de Parapléjicos de ToledoNCT05398913Written as Rimonabant
- The Effects of Rimonabant, on Weight and Metabolic Risk FactorsTerminatedPhase 2University of Maryland, BaltimoreNCT00547118Written as Rimonabant
- Rimonabant to Reduce Alcohol ConsumptionCompletedPhase 2National Institute on Alcohol Abuse and Alcoholism (NIAAA)NCT00075205Written as SR141716 (Rimonabant)
- Clinical and Neurobiological Effects of Cannabis Dependence in Young AdultsCompletedPhase 2The Scripps Research InstituteNCT00656487Written as rimonabant
- Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and ExerciseTerminatedPhase 3SanofiNCT00478972Written as Rimonabant
- VIsceral Fat Reduction Assessed by CT-scan On RImonabAntCompletedPhase 3SanofiNCT00299325Written as Rimonabant
- Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients With Oral Anti-diabetic DrugTerminatedPhase 3SanofiNCT00478595Written as Rimonabant
- Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on RimonabantTerminatedPhase 3SanofiNCT00228176Written as Rimonabant
- Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and OutcomesTerminatedPhase 3SanofiNCT00263042Written as Rimonabant
- An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients With Type 2 DiabetesTerminatedPhase 3SanofiNCT00577148Written as Rimonabant
- An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without DiabetesTerminatedPhase 3SanofiNCT00576667Written as Rimonabant
- Rimonabant In Prediabetic Subjects To Delay Onset Of Type 2 DiabetesTerminatedPhase 3SanofiNCT00325650Written as Rimonabant
- Effect of Rimonabant and Metformin Combination on Glycemic Control in Patients With Type 2 DiabetesTerminatedPhase 3SanofiNCT00690456Written as Rimonabant
- Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 DiabetesWithdrawnPhase 3SanofiNCT00754689Written as Rimonabant
- A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 DiabetesTerminatedPhase 3SanofiNCT00449605Written as Rimonabant
See all 46 studies that test Rimonabant →
Given beside what is tested · 1 — Rimonabant is usual care or a partner of the new treatment
What changed recently
From the registry's own updates since Oct 18, 2026.
Newly registered2
- Rimonabant for Cognitive Impairment in People With Post-COVID-19 SyndromeNov 12, 2026NCT07930637
- Rimonabant for Improving Walking Ability in Patients With Chronic StrokeNov 3, 2026NCT07913763
Codes
What other systems call Rimonabant · ClinicalTrials.gg INT006687
- MeSH (NLM) D000077285RimonabantConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) RML78EN3XERIMONABANTConfirmed FDA, NLM, Wikidata
- Wikidata Q412529rimonabantConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C73244RimonabantOne source FDA
- DrugBank DB06155One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077285 | Rimonabant | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | RML78EN3XE | RIMONABANT | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q412529 | rimonabant | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C73244 | Rimonabant | One source FDA |
| DrugBank | DB06155 | — | One source Wikidata |
Also registered as rimonabant hydrochloride (UNII HL0V2LQZ09).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.